H. Kirk Hammond - La Jolla CA Paul A. Insel - La Jolla CA Peipei Ping - Marina del Rey KY Steven R. Post - Lexington KY Meihua Gao - San Diego CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 3500
US Classification:
424 932, 424 931, 4353201
Abstract:
The present invention relates to methods and compositions for enhancing cardiac function in mammalian hearts by inserting transgenes that increase beta-adrenergic responsiveness within the myocardium. The present invention can thus be used in the treatment of heart disease, especially congestive heart failure.
H. Hammond - La Jolla CA, US Paul Insel - San Diego CA, US Peipei Ping - Jeffersonville IN, US Steven Post - Lexington KY, US Meihua Gao - San Diego CA, US
International Classification:
A61K048/00
US Classification:
514/044000, 435/320100
Abstract:
The present invention relates to methods and compositions for enhancing cardiac function in mammalian hearts by inserting transgenes that increase beta-adrenergic responsiveness within the myocardium. The present invention can thus be used in the treatment of heart disease, especially congestive heart failure.
H. Kirk Hammond - La Jolla CA Paul A. Insel - San Diego CA Peipei Ping - Jeffersonville IN Steven R. Post - Lexington KY Meihua Gao - San Diego CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 4800 A61K 3500 C12N 1563 C12N 700
US Classification:
514 44
Abstract:
The present invention relates to methods and compositions for enhancing cardiac function in mammalian hearts by inserting transgenes that increase. beta. -adrenergic responsiveness within the myocardium. The present invention can thus be used in the treatment of heart disease, especially congestive heart failure.